PhD Investigator Clinical
Mass General Research Institute
Massachusetts General Hospital
Associate Professor of Psychology in the Department of Psychiatry
Harvard Medical School
antipsychotic agents; cbt; clozapine; cognitive behavior therapy for schizophrenia; cognitive behavioral therapy; cognitive therapy; psychotic disorders; schizophrenia; schizophrenic psychology; smokers with schizophrenia; smoking cessation; varenicline
Dr. Cather's research interests include the development and implementation of CBT to residual symptoms, medication adherence, and substance use disorders in individuals with schizophrenia spectrum disorders. Her group was the lead site for the first randomized controlled trial of CBT in schizophrenia published in the United States. She has authored several manualized treatment protocols for increasing readiness to quit smoking, smoking cessation, and smoking relapse prevention that are based on cognitive-behavioral and motivational enhancement principles for smokers with severe mental illness diagnoses and has trained interventionists across the US to deliver these treatments with high fidelity to the model.